Irbesartan Pharmakern

Irbesartan, the active ingredient in Irbesartan Pharmakern, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to manage high blood pressure and to protect kidney function in patients with diabetic nephropathy by selectively blocking the AT1 receptor, reducing vascular resistance and aldosterone secretion.

GNH USA supplies Irbesartan Pharmakern as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan acts on the renin‑angiotensin‑aldosterone system to treat several cardiovascular and renal conditions. - Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. - Diabetic nephropathy: slows decline of renal function in patients with type 2 diabetes. - Chronic kidney disease associated with diabetes: helps reduce proteinuria and preserve kidney function.

Irbesartan may cause a range of adverse reactions, which are classified by frequency.

Common Side Effects: - Dizziness - Headache - Fatigue

Serious or Rare Side Effects: - Angioedema (swelling of face, lips, tongue) - Hyperkalemia (elevated blood potassium) - Acute kidney injury

When prescribing Irbesartan, clinicians should consider several safety measures. - Blood pressure monitoring: check regularly to ensure therapeutic effect. - Renal function assessment: evaluate serum creatinine and eGFR before and during therapy. - Serum potassium monitoring: avoid hyperkalemia, especially with potassium‑sparing agents. - Pregnancy avoidance: do not use during pregnancy due to potential fetal harm. - Hepatic impairment caution: adjust use in patients with liver disease. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Irbesartan can interact with several medicines; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid): - Aliskiren in diabetic patients: combined use can increase renal risk. - Potassium‑sparing diuretics (e.g., spironolactone): may cause dangerous hyperkalemia. - ACE inhibitors: concurrent use raises risk of angioedema and renal impairment.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may enhance hypotensive effect, monitor blood pressure. - NSAIDs (high dose): can reduce antihypertensive effect and impair renal function. - Rifampin: may lower irbesartan plasma concentrations, consider dose adjustment.